Effect of lorcaserin on weight reduction in persons with obstructive sleep apnea (OSA): a combined subgroup analysis from three randomized, controlled clinical trials

STUDY OBJECTIVES: To evaluate weight loss with lorcaserin in persons with obstructive sleep apnea (OSA). METHODS: This retrospective analysis evaluated weight loss of lorcaserin (10 mg twice daily) versus placebo in persons with obesity or overweight persons with OSA from a pooled database of three...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujioka, K., Perdomo, C., Malhotra, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587310/
https://www.ncbi.nlm.nih.gov/pubmed/31275597
http://dx.doi.org/10.1002/osp4.340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587310/
https://www.ncbi.nlm.nih.gov/pubmed/31275597
http://dx.doi.org/10.1002/osp4.340

Ejemplares similares